Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
13
APYP Quote, Financials, Valuation and Earnings
Last price:
$0.0100
Seasonality move
:
30.43%
Day range:
$0.0058 - $0.0100
52-week range:
$0.0057 - $0.0240
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
150.51x
P/B ratio:
--
Volume:
46.5K
Avg. volume:
32.4K
1-year change:
-74.22%
Market cap:
$3.1M
Revenue:
$29K
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, AppYea has -- downside to fair value with a price target of -- per share.
APYP vs. S&P 500
-
Over the past 5 trading days, AppYea has overperformed the S&P 500 by 19.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AppYea does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AppYea revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter AppYea reported revenues of $3K.
Earnings Growth
-
AppYea has grown year-over-year earnings for 0 quarters straight. In the most recent quarter AppYea reported earnings per share of -$0.00.
Enterprise value:
9.5M
EV / Invested capital:
--
Price / LTM sales:
150.51x
EV / EBIT:
--
EV / Revenue:
501.35x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-14.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$3K
Return On Assets:
-653.54%
Net Income Margin (TTM):
-15547.37%
Return On Equity:
--
Return On Invested Capital:
-7348.26%
Operating Margin:
-4100%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | $19K | $13K | $3K | |
| Gross Profit | -- | $10K | $3K | $10K | -$1K | |
| Operating Income | -$2.1M | -$1.6M | -$1.5M | -$398K | -$123K | |
| EBITDA | -$1.2M | -$1.6M | -$3.5M | -$392K | -$117K | |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.00 | -$0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $118K | $418K | $162K | |
| Total Assets | -- | -- | $237K | $658K | $411K | |
| Current Liabilities | -- | -- | $2.6M | $3.8M | $1.7M | |
| Total Liabilities | -- | -- | $2.6M | $3.8M | $4.6M | |
| Total Equity | -- | -- | -$2.4M | -$3.2M | -$4.2M | |
| Total Debt | -- | -- | $2.2M | $3.1M | $4.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$565K | -$757K | -$631K | -$257K | -$103K | |
| Cash From Investing | -- | -$143K | -$31K | -$50K | -$1K | |
| Cash From Financing | $583K | $1.2M | $387K | $456K | $124K | |
| Free Cash Flow | -$565K | -$900K | -$662K | -$307K | -$104K | |
APYP
Sector
Market Cap
$3.1M
--
Price % of 52-Week High
24.17%
--
Dividend Yield
0%
--
Shareholder Yield
-11.02%
--
1-Year Price Total Return
-54.55%
--
Beta (5-Year)
147.653
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0084
200-day SMA
Sell
Level
$0.0130
Bollinger Bands (100)
Sell
Level
0.012 - 0.012
Chaikin Money Flow
Buy
Level
645
20-day SMA
Sell
Level
$0.0098
Relative Strength Index (RSI14)
Sell
Level
39.1736
ADX Line
Buy
Level
23.3843
Williams %R
Neutral
Level
-28.3333
50-day SMA
Sell
Level
$0.0104
MACD (12, 26)
Buy
Level
0.0023
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-80.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-74.5157)
Sell
CA Score
(Annual)
Level (-78.8945)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (1)
Sell
Ohlson Score
Level (101.9985)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AppYea Inc, through its wholly-owned subsidiary SleepX, is an Israeli research and development company that has developed a product for monitoring and treating sleep apnea and snoring. It is a digital health company, focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. Its solutions are based on its proprietary intellectual property portfolio, comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during sleep time, offering extreme accuracy at an affordable cost.
Stock Forecast FAQ
In the current month, APYP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The APYP average analyst price target in the past 3 months is --.
-
Where Will AppYea Stock Be In 1 Year?
According to analysts, the consensus estimate is that AppYea share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About AppYea?
Analysts are divided on their view about AppYea share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AppYea is a Sell and believe this share price will rise from its current level to --.
-
What Is AppYea's Price Target?
The price target for AppYea over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is APYP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AppYea is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of APYP?
You can purchase shares of AppYea via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AppYea shares.
-
What Is The AppYea Share Price Today?
AppYea was last trading at $0.0100 per share. This represents the most recent stock quote for AppYea. Yesterday, AppYea closed at $0.0058 per share.
-
How To Buy AppYea Stock Online?
In order to purchase AppYea stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
